SCHEMBL2727043

SCHEMBL2727043

COc1ccc(-c2c3ccccc3c(-c3ccc(F)c(F)c3)c3c(F)c(F)c(F)c(F)c23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.46
STAT3 P40763 1/20 0.43
ACHE P22303 1/20 0.43
POLB P06746 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAOB P27338 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ABL1 P00519 1/20 0.37
ABCB1 P08183 1/20 0.37
BCR P11274 1/20 0.37
ALOX5 P09917 1/20 0.37
ACACA Q13085 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2727044 0.91 L3MBTL1 (0.48) L3MBTL1STAT3ACHEPOLBKDM4E
SCHEMBL2728448 0.90 L3MBTL1 (0.44) L3MBTL1ACHEKDM4EALDH1A1MAPT
SCHEMBL2711584 0.90 ACHE (0.51) L3MBTL1STAT3ACHEPOLBKDM4E
SCHEMBL2944198 0.90 L3MBTL1 (0.46) L3MBTL1STAT3POLBALDH1A1MAPT
SCHEMBL12086227 0.89 L3MBTL1 (0.40) L3MBTL1STAT3ACHEPOLBALDH1A1
SCHEMBL2731490 0.89 L3MBTL1 (0.40) L3MBTL1STAT3ACHEPOLBALDH1A1
SCHEMBL2944689 0.89 L3MBTL1 (0.39) L3MBTL1STAT3ACHEPOLBKDM4E
SCHEMBL12086091 0.88 MEN1 (0.42) L3MBTL1STAT3POLBKDM4EALDH1A1
SCHEMBL2712297 0.88 MEN1 (0.42) L3MBTL1STAT3POLBKDM4EALDH1A1
SCHEMBL2710955 0.87 L3MBTL1 (0.49) L3MBTL1STAT3ACHEPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 L3MBTL1 2477/4885STAT3 3366/4885ACHE 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.